Literature DB >> 12719974

Epithelial-myoepithelial carcinoma of the parotid gland-evidence of contrasting DNA patterns in two different histological parts.

Britta Kleist1, Micaela Poetsch, Christel Breitsprecher, Godela Düsterbehn, Karl Donath, Gerd Lorenz.   

Abstract

Epithelial-myoepithelial carcinoma (EMC) is a rare neoplasm arising predominantly in the salivary glands, in particular in the parotid gland. We report the morphological features of an epithelial-myoepithelial carcinoma of the parotid gland with one lymph-node metastasis including a molecular genetic study of this tumor. Immunohistochemical and ultrastructural results confirmed the epithelial-myoepithelial dualism of the carcinoma. The loss of heterozygosity (LOH) analysis revealed different LOH results for the solid and the tubular growth pattern of the primary tumor, but showed identical findings for the solid primary tumor component and the lymph node metastasis which had also a solid appearance. LOH could be demonstrated in the whole primary tumor at D13S217 (13q12) and D18S58 (18q21). In three other microsatellite loci [D9S162 (9p22-p21), D10S251 and D10S541 (surrounding the PTEN/MMAC1 gene on 10q23-q24)], clearly recognizable LOH was found in the solid part and in the metastasis, whereas the tubular component demonstrated only a slight decrease of the same allele. No mutation or methylation of the p16 gene or alteration of the PTEN/MMAC1 gene could be found. Nevertheless, our results provoke a discussion, whether these genetic alterations could be considered as determinants of histologically and prognostically divergent types in EMC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719974     DOI: 10.1007/s00428-003-0800-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

1.  Semiautomated assessment of loss of heterozygosity and replication error in tumors.

Authors:  F Canzian; R Salovaara; A Hemminki; P Kristo; R B Chadwick; L A Aaltonen; A de la Chapelle
Journal:  Cancer Res       Date:  1996-07-15       Impact factor: 12.701

2.  High-grade carcinoma component in epithelial-myoepithelial carcinoma of salivary glands clinicopathological, immunohistochemical and flow-cytometric study of three cases.

Authors:  L Alos; R Carrillo; J Ramos; J M Baez; C Mallofre; P L Fernandez; A Cardesa
Journal:  Virchows Arch       Date:  1999-04       Impact factor: 4.064

3.  Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Authors:  Marc Ladanyi; Cristina R Antonescu; Denis H Leung; James M Woodruff; Akira Kawai; John H Healey; Murray F Brennan; Julia A Bridge; James R Neff; Frederic G Barr; Jeffrey D Goldsmith; John S J Brooks; John R Goldblum; Syed Z Ali; Janet Shipley; Colin S Cooper; Cyril Fisher; Björn Skytting; Olle Larsson
Journal:  Cancer Res       Date:  2002-01-01       Impact factor: 12.701

4.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

5.  Clear cell chondrosarcoma of the larynx: a case report of a rare histologic variant in an uncommon localization.

Authors:  B Kleist; M Poetsch; C Lang; A Bankau; G Lorenz; K Süess-Fridrich; G Jundt; E Wolf
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

6.  Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines.

Authors:  A Gemma; S Takenoshita; K Hagiwara; A Okamoto; E A Spillare; M G McMemamin; S P Hussain; K Forrester; M Zariwala; Y Xiong; C C Harris
Journal:  Int J Cancer       Date:  1996-11-27       Impact factor: 7.396

7.  Proliferating cell nuclear antigen immunohistochemistry in epithelial-myoepithelial carcinoma of the salivary glands.

Authors:  I Fonseca; J Soares
Journal:  Arch Pathol Lab Med       Date:  1993-10       Impact factor: 5.534

8.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Malignant salivary gland neoplasms: a cytogenetic study of 19 cases.

Authors:  C Martins; I Fonseca; L Roque; A E Pinto; J Soares
Journal:  Eur J Cancer B Oral Oncol       Date:  1996-03

10.  Deletion of the p16 gene and microsatellite instability in carcinoma arising in pleomorphic adenoma of the parotid gland.

Authors:  H Suzuki; Y Fujioka
Journal:  Diagn Mol Pathol       Date:  1998-08
View more
  2 in total

1.  High frequency of loss of PTEN expression in human solid salivary adenoid cystic carcinoma and its implication for targeted therapy.

Authors:  Han Liu; Li Du; Ru Wang; Chao Wei; Bo Liu; Lei Zhu; Pixu Liu; Qiang Liu; Jiang Li; Shi-Long Lu; Jing Xiao
Journal:  Oncotarget       Date:  2015-05-10

2.  Cooperation Between Pten and Smad4 in Murine Salivary Gland Tumor Formation and Progression.

Authors:  Yu Cao; Han Liu; Liwei Gao; Ling Lu; Li Du; Han Bai; Jiang Li; Sherif Said; Xiao-Jing Wang; John Song; Natalie Serkova; Minjie Wei; Jing Xiao; Shi-Long Lu
Journal:  Neoplasia       Date:  2018-06-27       Impact factor: 5.715

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.